VIGOR Study Design Dose

• Rofecoxib 50 mg/day

  • 2X upper dose labeled for chronic use in OA

• Naproxen 500 mg b.i.d.

  • maximum labeled dose for chronic use in OA and RA

• Rofecoxib not currently labeled for use in RA

Previous slide

Next slide

Back to first slide

View graphic version